Press Release
UPMC and IBM to Apply Artificial Intelligence, Machine Learning to Transform Health Care Supply Chain
In an effort to apply data-driven insights to one of the most fundamental aspects of running a health care system, UPMC announced today that it has formed Pensiamo, an independent company that aims to help hospitals improve supply chain performance through a comprehensive source-to-pay offering, including cognitive analytics with IBM Watson Health technologies. IBM (NYSE:IBM) is a minority owner of Pensiamo. Supply chain costs are the second-largest and fastest-growing expense behind labor costs for health care providers [1]. The Institute of Medicine estimates that nearly one-third of health care spending is waste [2]. In today's dynamic environment, providers face mounting pressure to improve the effectiveness of patient care while controlling costs.
Startup Launches Replica of Alexis Ohanian Using Artificial Intelligence
Additionally they used 3-D printing to replicate the body of Alexis Ohanian, infusing it with their proprietary Artificial Intelligence engine. "There's a lack of qualified IT professionals here in Armenia", said Dr. J.P. Hagopian, the CEO of 1AI Solutions. "We need to hire people, but we simply can't find enough good candidates. At some point our HR manager said that we should clone one of the high-performing Silicon Valley guys. She was kidding, but the idea stuck."
UPMC and IBM to Apply Artificial Intelligence, Machine Learning to Transform Health Care Supply Chain
In an effort to apply data-driven insights to one of the most fundamental aspects of running a health care system, UPMC announced today that it has formed Pensiamo, an independent company that aims to help hospitals improve supply chain performance through a comprehensive source-to-pay offering, including cognitive analytics with IBM Watson Health technologies. IBM (NYSE: IBM) is a minority owner of Pensiamo. Supply chain costs are the second-largest and fastest-growing expense behind labor costs for health care providers [1]. The Institute of Medicine estimates that nearly one-third of health care spending is waste [2]. In today's dynamic environment, providers face mounting pressure to improve the effectiveness of patient care while controlling costs.
Business Machines : UPMC and IBM to Apply Artificial Intelligence, Machine Learning to Transform Health Care Supply Chain 4-Traders
In an effort to apply data-driven insights to one of the most fundamental aspects of running a health care system, UPMC announced today that it has formed Pensiamo, an independent company that aims to help hospitals improve supply chain performance through a comprehensive source-to-pay offering, including cognitive analytics with IBM Watson Health technologies. IBM (NYSE:IBM) is a minority owner of Pensiamo. Supply chain costs are the second-largest and fastest-growing expense behind labor costs for health care providers [1]. The Institute of Medicine estimates that nearly one-third of health care spending is waste [2]. In today's dynamic environment, providers face mounting pressure to improve the effectiveness of patient care while controlling costs.
Machine learning startup Dato changes name to Turi after trademark battle
Seattle-based machine learning startup Dato, which originally launched as GraphLab, announced today that it has changed its name again. Now, the company is known as Turi, an ode to computer science legend Alan Turing. This past September, Turi -- then Dato -- found itself in a trademark infringement argument with fellow tech startup Datto after Dato changed its name from GraphLab in January 2015. Datto, which has been offering data backup and recovery services from its Connecticut headquarters since 2007, first complained about Dato's new name just weeks after the company finished its rebranding from GraphLab. Datto argued that Dato's new name would cause confusion.
Startup Launches Artificial Intelligence Tool to Diagram Corporate Structures
A new legal technology company called Deftr is today launching a tool powered by artificial intelligence that helps professionals diagram intricate corporate structures. The tool reads text in real time, as it is being typed, then turns that text into a shareable, interactive graphic illustrating a corporate structure or transaction. In a press release being issued today, Deftr's co-founder and CEO Matthew Osman explained: Building charts to represent corporate structures or transactions essentially by hand is a laborious process all too familiar to anyone in corporate life. It's the reason a lot of associates don't have weekends. Our tool automates this outdated, manual process, allowing a user to build a chart in a fraction of the time and focus their efforts on high-level, analytical work. The tool should be of value to law firms, in-house legal departments, accounting firms, financial services and management consultants, Deftr says.
Linkedin Meets Amazon.com : Zoondy Raises a New Funding Round on Fundable to Accelerate the Future of Work
By 2020 50% or more of the U.S. workforce are expected to be on-demand workers / contingent workers in the liquid workforce. Zoondy capitalizes on this paradigm shift by utilizing a commodity brokerage approach to create a marketplace for seasoned professionals to sell their skills and expertise in four unique ways: free, fixed price, auction and goal pricing. Zoondy provides a secure, structured market environment for buyers and sellers of professional high-skill expertise to transact for the knowledge, expertise and skills that they need on a short term or project basis. While most associate freelance and onโdemand workers with creative engagements, at best or un-skilled hourly gig workers, at worst, like Uber drivers, Fivver or Upwork; Zoondy targets the 43 million seasoned professionals, retirees and work-from-home executives who have proven expertise that can be shared locally or globally with businesses both small and large. For seasoned professionals, a Zoondy profile takes only minutes to set up and when completed the platform immediately begins marketing a user's skills.
Startup Launches Replica of Alexis Ohanian Using Artificial Intelligence
NEW YORK, July 6, 2016 /PRNewswire-USNewswire/ -- Thanks to his business acumen, poster boy looks, and relentless activism for freedom of the internet, Reddit's co-founder Alexis Ohanian has become one of the most high-profile residents of Brooklyn. A startup based in Armenia and San Francisco named 1AI Solutions has recently launched a working AI-based version of Alexis Ohanian named Avedis Ohanian. Additionally they used 3-D printing to replicate the body of Alexis Ohanian, infusing it with their proprietary Artificial Intelligence engine. "There's a lack of qualified IT professionals here in Armenia", said Dr. J.P. Hagopian, the CEO of 1AI Solutions. "We need to hire people, but we simply can't find enough good candidates. At some point our HR manager said that we should clone one of the high-performing Silicon Valley guys. She was kidding, but the idea stuck."
Over a Third of Big Data Developers Working with Machine Learning - Press Release Rocket
July 6, 2016, Over a third (36%) of all developers who are actively working on Big Data or advanced analytics projects now use elements of machine learning according to Evans Data's recently released Big Data and Advanced Analytics survey report. While the market for machine learning is still fragmented, those developers actively working with machine learning are most likely to be targeting financial sectors, Internet of Things, or manufacturing. The survey of over 500 developers actively working with Big Data also showed that decision trees are the most used analytical model which links in closely with artificial intelligence and machine learning development. Linear regression and logistics regression were the next most cited analytical models. Logistics, distribution, or operations were the company departments most likely to be using advanced data analytics or Big Data solutions.
The first AI system for human embryonic state analysis is available for testing - Scienmag
"BioTime harnesses the largest collection of highest-quality gene expression data coming from scrupulously designed and controlled cell differentiation experiments we have seen to date. It was large enough to train a complex architecture of deep neural networks to work as a classifier and a predictor of the embryonic state. We recently tested Embryonic.AI using mouse data and noticed surprising results showing the capabilities of this system in cross-species analysis. Research projects using Embryonic.AI may transform our understanding of cancer and other diseases and possible developments in reinforcement learning may help navigate and control cellular differentiation states", said Alex Zhavoronkov, Ph.D., CEO of Insilico Medicine, Inc. The system utilizes a sophisticated architecture of multi-class deep neural networks (DNNs) and DNN ensembles trained on thousands of samples of carefully selected cells of multiple classes: embryonic stem cells, induced pluripotent stem cells, progenitor stem cells, adult stem cells and adult cells to recognize the class and embryonic state of the sample, achieving high accuracy in simulations.